Advanced or Metastatic Urothelium Cancer Clinical Trials in Beijing, Beijing Municipality

A Study of MRG002 Versus Investigator's Choice of Chemotherapy in the Treatment of Patients With HER2-positive Unresectable Advanced or Metastatic Urothelial Cancer